Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review

Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as obesity and diabetes mellitus, leading to increased mortality. Antipsychotics (APs), which are the mainstay in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Raghunath, Stogios, Nicolette, Smith, Emily, Lee, Jiwon, Maksyutynsk, Kateryna, Au, Emily, Wright, David C., De Palma, Giada, Graff-Guerrero, Ariel, Gerretsen, Philip, Müller, Daniel J., Remington, Gary, Hahn, Margaret, Agarwal, Sri Mahavir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118432/
https://www.ncbi.nlm.nih.gov/pubmed/35600753
http://dx.doi.org/10.1177/20451253221096525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118432/
https://www.ncbi.nlm.nih.gov/pubmed/35600753
http://dx.doi.org/10.1177/20451253221096525

Ejemplares similares